Ravi Viswanathan Insider Trading $LOXO Loxo Oncology, Inc.

Get the latest insider transactions of Ravi Viswanathan. Ravi Viswanathan is 10% Owner in INTERLEUKIN GENETICS INC ($ILIU) and 10% Owner in Achaogen Inc ($AKAO) and 10% Owner in AVEO PHARMACEUTICALS INC ($AVEO) and 10% Owner in Workday, Inc. ($WDAY) and 10% Owner in AEROHIVE NETWORKS, INC ($HIVE) and 10% Owner in BOX INC ($BOX) and 10% Owner in MULESOFT, INC ($MULE) and 10% Owner in Millennial Media Inc. ($MM) and 10% Owner in Tracon Pharmaceuticals, Inc. ($TCON) and 10% Owner in Cascadian Therapeutics, Inc. ($CASC) and 10% Owner in Care.com Inc ($CRCM) and 10% Owner in ARDELYX, INC. ($ARDX) and 10% Owner in APPIAN CORP ($APPN) and 10% Owner in Mersana Therapeutics, Inc. ($MRSN) and 10% Owner in Clovis Oncology, Inc. ($CLVS) and 10% Owner in Roka BioScience, Inc. ($ROKA) and 10% Owner in Omthera Pharmaceuticals, Inc. ($OMTH) and Director in Omthera Pharmaceuticals, Inc. ($OMTH) and 10% Owner in Ra Pharmaceuticals, Inc. ($RARX) and 10% Owner in TESARO, Inc. ($TSRO) and 10% Owner in CVENT INC ($CVT) and 10% Owner in Mirna Therapeutics, Inc. ($MIRN) and 10% Owner in Cerecor Inc. ($CERC) and 10% Owner in Dermira, Inc. ($DERM) and 10% Owner in Epizyme, Inc. ($EPZM) and 10% Owner in Loxo Oncology, Inc. ($LOXO) and 10% Owner in Adaptimmune Therapeutics PLC ($ADAP) and 10% Owner in RHYTHM PHARMACEUTICALS, INC. ($RYTM) and 10% Owner in Elastic N.V. ($ESTC) and 10% Owner in Surface Oncology, Inc. ($SURF).